JP Morgan Chase
ENTX icon

JP Morgan Chase’s Entera Bio ENTX Stock Holding History

JP Morgan Chase’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.5K Buy
40,883
+33,733
+472% +$42.2K ﹤0.01% 6294
2026
Q1 		$7.15K Buy
+7,150
New +$10K ﹤0.01% 6818
2024
Q4 		– Sell
-2
Closed -$4 – 7466
2024
Q3 		$4 Buy
+2
New +$4 ﹤0.01% 7332
2024
Q2 		– Sell
-2
Closed -$3 – 7445
2024
Q1 		$3 Buy
+2
New +$2 ﹤0.01% 7291
2023
Q2 		– Sell
-1,868
Closed -$2K – 7025
2023
Q1 		$2K Buy
+1,868
New +$1.87K ﹤0.01% 6415
2022
Q1 		– Sell
-2
Closed – – 6698
2021
Q4 		$0 Hold
2
– – ﹤0.01% 6727
2021
Q3 		$0 Buy
+2
New +$10 ﹤0.01% 6555

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

JP Morgan Chase's ENTX Position: Q2 2026 in Review

JP Morgan Chase increased its Entera Bio (ENTX) stake by 472% in Q2 2026, buying an estimated $42.2K and bringing the position to 40,883 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6294.

JP Morgan Chase first reported a position in ENTX in Q3 2021 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • JP Morgan Chase held 40,883 shares of Entera Bio worth $67.5K as of Q2 2026.
  • JP Morgan Chase bought 33,733 Entera Bio shares in Q2 2026, an estimated $42.2K.
  • Entera Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6294 holding.
  • JP Morgan Chase first reported a position in Entera Bio in Q3 2021 and has held it in 7 quarters since.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.